US Stock MarketDetailed Quotes

CHRS Coherus BioSciences

Watchlist
  • 1.995
  • +0.065+3.37%
Trading Apr 26 10:55 ET
226.43MMarket Cap-788P/E (TTM)

Coherus BioSciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
21.89%257.24M
101.81%91.52M
64.16%74.57M
-2.39%58.72M
-46.04%32.44M
-35.37%211.04M
-38.19%45.35M
-44.94%45.42M
-31.37%60.15M
-27.60%60.12M
Operating revenue
21.89%257.24M
101.81%91.52M
64.16%74.57M
-2.39%58.72M
-46.04%32.44M
-35.37%211.04M
-38.19%45.35M
-44.94%45.42M
-31.37%60.15M
-27.60%60.12M
Cost of revenue
126.86%158.99M
495.46%84.57M
-7.18%32.7M
120.34%24.85M
80.09%16.87M
21.69%70.08M
17.33%14.2M
65.57%35.23M
-32.46%11.28M
24.75%9.37M
Gross profit
-30.30%98.25M
-77.67%6.96M
310.84%41.87M
-30.70%33.87M
-69.33%15.56M
-47.59%140.96M
-49.16%31.15M
-83.36%10.19M
-31.11%48.87M
-32.81%50.75M
Operating expense
-24.23%301.45M
-8.21%75.86M
-18.50%73.87M
-26.35%68.41M
-36.73%83.31M
-25.33%397.84M
-18.02%82.64M
-3.59%90.64M
-2.34%92.89M
-45.79%131.67M
Selling and administrative expenses
-3.26%192.02M
-7.70%49.49M
7.57%48.22M
-11.96%45.14M
0.82%49.15M
16.95%198.48M
7.13%53.62M
12.29%44.83M
27.09%51.28M
23.77%48.75M
Research and development costs
-45.11%109.44M
-9.14%26.37M
-44.01%25.65M
-44.08%23.27M
-58.81%34.15M
-45.10%199.36M
-42.83%29.02M
-15.30%45.81M
-24.02%41.61M
-59.25%82.92M
Operating profit
20.90%-203.2M
-33.81%-68.91M
60.22%-32.01M
21.52%-34.54M
16.29%-67.75M
2.64%-256.88M
-30.21%-51.49M
-145.37%-80.45M
-82.14%-44.01M
51.65%-80.93M
Net non-operating interest income expense
-24.84%-40.54M
-13.15%-10.62M
-36.18%-10.27M
-51.11%-9.94M
-8.28%-9.71M
-41.44%-32.47M
-62.01%-9.39M
-30.65%-7.54M
-14.49%-6.58M
-58.80%-8.97M
Non-operating interest expense
24.84%40.54M
13.15%10.62M
36.18%10.27M
51.11%9.94M
8.28%9.71M
41.44%32.47M
62.01%9.39M
30.65%7.54M
14.49%6.58M
58.80%8.97M
Other net income (expense)
327.88%5.47M
-106.42%-129K
68.26%2.25M
265.01%1.62M
127.92%1.73M
-748.06%-2.4M
621.56%2.01M
4,363.33%1.34M
3,927.27%443K
-10,247.54%-6.19M
Special income (charges)
--0
--0
--0
--0
--0
---6.22M
--0
--0
--0
---6.22M
-Less:Other special charges
----
----
----
----
----
--6.22M
--0
----
----
--6.22M
Other non- operating income (expenses)
43.09%5.47M
-106.42%-129K
68.26%2.25M
265.01%1.62M
5,300.00%1.73M
1,450.53%3.82M
621.56%2.01M
4,363.33%1.34M
3,927.27%443K
-47.54%32K
Income before tax
18.33%-238.27M
-35.30%-79.65M
53.81%-40.02M
14.52%-42.87M
21.18%-75.73M
-1.62%-291.75M
-28.75%-58.87M
-124.90%-86.65M
-67.73%-50.15M
44.44%-96.08M
Income tax
-380K
0
-380K
0
0
0
0
0
0
0
Net income
18.46%-237.89M
-35.30%-79.65M
54.25%-39.64M
14.52%-42.87M
21.18%-75.73M
-1.62%-291.75M
-28.75%-58.87M
-124.90%-86.65M
-67.73%-50.15M
44.44%-96.08M
Net income continuous Operations
18.46%-237.89M
-35.30%-79.65M
54.25%-39.64M
14.52%-42.87M
21.18%-75.73M
-1.62%-291.75M
-28.75%-58.87M
-124.90%-86.65M
-67.73%-50.15M
44.44%-96.08M
Minority interest income
Net income attributable to the parent company
18.46%-237.89M
-35.30%-79.65M
54.25%-39.64M
14.52%-42.87M
21.18%-75.73M
-1.62%-291.75M
-28.75%-58.87M
-124.90%-86.65M
-67.73%-50.15M
44.44%-96.08M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
18.46%-237.89M
-35.30%-79.65M
54.25%-39.64M
14.52%-42.87M
21.18%-75.73M
-1.62%-291.75M
-28.75%-58.87M
-124.90%-86.65M
-67.73%-50.15M
44.44%-96.08M
Basic earnings per share
32.71%-2.53
2.63%-0.74
63.06%-0.41
24.62%-0.49
22.58%-0.96
1.31%-3.76
-26.67%-0.76
-126.53%-1.11
-62.50%-0.65
47.68%-1.24
Diluted earnings per share
32.71%-2.53
2.63%-0.74
63.06%-0.41
24.62%-0.49
22.58%-0.96
1.31%-3.76
-26.67%-0.76
-126.53%-1.11
-62.50%-0.65
47.68%-1.24
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 21.89%257.24M101.81%91.52M64.16%74.57M-2.39%58.72M-46.04%32.44M-35.37%211.04M-38.19%45.35M-44.94%45.42M-31.37%60.15M-27.60%60.12M
Operating revenue 21.89%257.24M101.81%91.52M64.16%74.57M-2.39%58.72M-46.04%32.44M-35.37%211.04M-38.19%45.35M-44.94%45.42M-31.37%60.15M-27.60%60.12M
Cost of revenue 126.86%158.99M495.46%84.57M-7.18%32.7M120.34%24.85M80.09%16.87M21.69%70.08M17.33%14.2M65.57%35.23M-32.46%11.28M24.75%9.37M
Gross profit -30.30%98.25M-77.67%6.96M310.84%41.87M-30.70%33.87M-69.33%15.56M-47.59%140.96M-49.16%31.15M-83.36%10.19M-31.11%48.87M-32.81%50.75M
Operating expense -24.23%301.45M-8.21%75.86M-18.50%73.87M-26.35%68.41M-36.73%83.31M-25.33%397.84M-18.02%82.64M-3.59%90.64M-2.34%92.89M-45.79%131.67M
Selling and administrative expenses -3.26%192.02M-7.70%49.49M7.57%48.22M-11.96%45.14M0.82%49.15M16.95%198.48M7.13%53.62M12.29%44.83M27.09%51.28M23.77%48.75M
Research and development costs -45.11%109.44M-9.14%26.37M-44.01%25.65M-44.08%23.27M-58.81%34.15M-45.10%199.36M-42.83%29.02M-15.30%45.81M-24.02%41.61M-59.25%82.92M
Operating profit 20.90%-203.2M-33.81%-68.91M60.22%-32.01M21.52%-34.54M16.29%-67.75M2.64%-256.88M-30.21%-51.49M-145.37%-80.45M-82.14%-44.01M51.65%-80.93M
Net non-operating interest income expense -24.84%-40.54M-13.15%-10.62M-36.18%-10.27M-51.11%-9.94M-8.28%-9.71M-41.44%-32.47M-62.01%-9.39M-30.65%-7.54M-14.49%-6.58M-58.80%-8.97M
Non-operating interest expense 24.84%40.54M13.15%10.62M36.18%10.27M51.11%9.94M8.28%9.71M41.44%32.47M62.01%9.39M30.65%7.54M14.49%6.58M58.80%8.97M
Other net income (expense) 327.88%5.47M-106.42%-129K68.26%2.25M265.01%1.62M127.92%1.73M-748.06%-2.4M621.56%2.01M4,363.33%1.34M3,927.27%443K-10,247.54%-6.19M
Special income (charges) --0--0--0--0--0---6.22M--0--0--0---6.22M
-Less:Other special charges ----------------------6.22M--0----------6.22M
Other non- operating income (expenses) 43.09%5.47M-106.42%-129K68.26%2.25M265.01%1.62M5,300.00%1.73M1,450.53%3.82M621.56%2.01M4,363.33%1.34M3,927.27%443K-47.54%32K
Income before tax 18.33%-238.27M-35.30%-79.65M53.81%-40.02M14.52%-42.87M21.18%-75.73M-1.62%-291.75M-28.75%-58.87M-124.90%-86.65M-67.73%-50.15M44.44%-96.08M
Income tax -380K0-380K0000000
Net income 18.46%-237.89M-35.30%-79.65M54.25%-39.64M14.52%-42.87M21.18%-75.73M-1.62%-291.75M-28.75%-58.87M-124.90%-86.65M-67.73%-50.15M44.44%-96.08M
Net income continuous Operations 18.46%-237.89M-35.30%-79.65M54.25%-39.64M14.52%-42.87M21.18%-75.73M-1.62%-291.75M-28.75%-58.87M-124.90%-86.65M-67.73%-50.15M44.44%-96.08M
Minority interest income
Net income attributable to the parent company 18.46%-237.89M-35.30%-79.65M54.25%-39.64M14.52%-42.87M21.18%-75.73M-1.62%-291.75M-28.75%-58.87M-124.90%-86.65M-67.73%-50.15M44.44%-96.08M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 18.46%-237.89M-35.30%-79.65M54.25%-39.64M14.52%-42.87M21.18%-75.73M-1.62%-291.75M-28.75%-58.87M-124.90%-86.65M-67.73%-50.15M44.44%-96.08M
Basic earnings per share 32.71%-2.532.63%-0.7463.06%-0.4124.62%-0.4922.58%-0.961.31%-3.76-26.67%-0.76-126.53%-1.11-62.50%-0.6547.68%-1.24
Diluted earnings per share 32.71%-2.532.63%-0.7463.06%-0.4124.62%-0.4922.58%-0.961.31%-3.76-26.67%-0.76-126.53%-1.11-62.50%-0.6547.68%-1.24
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion------------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg